Russian Almazov Center develops new radiopharmaceuticals to fight ischemic heart diseaseResearchers at the V. A. Almazov National Medical Research Centre have begun developing radiopharmaceuticals based on copper isotopes to diagnose ischemic heart disease. Overcoming Decay LogisticsThe study focuses on creating transportable pharmaceuticals for cardiology departments in regional areas that lack expensive isotope synthesis equipment. This extended window allows these agents to be produced at a centralized hub and transported to regional hospitals equipped with PET scanners. The Almazov Center intends to develop an independent technology for synthesis and quality control. Valeriy Klimov, cardiologist: "The use of isotopes with a long half-life is the only way to make high-precision ischemia diagnostics mass-market.